Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV.

Trial Profile

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Sep 2016

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Acronyms FLUHD
  • Most Recent Events

    • 26 Apr 2016 Results published in the Vaccine
    • 14 Jun 2013 Planned End Date changed from 1 May 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
    • 25 Oct 2012 Planned End Date changed from 1 May 2015 to 1 May 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top